BlueRock Therapeutics established its corporate headquarters in Cambridge, MA and has appointed two additional senior executive staffers. Source: BioSpace

BioMarin announced that the FDA granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation. Source: BioSpace

Teva said Lilly’s planned drug would infringe five patents that cover its own migraine drug, which it sought U.S. Food and Drug Administration approval for on Oct. 16. Source: BioSpace

Incyte has been at the forefront of the IDO race with its candidate epacadostat. Source: BioSpace

The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced. Source: BioSpace

You've probably heard those advertisements for "the power of protein," referring to the addition of enzymes to detergent. Source: BioSpace

Stryker picked up controlling interest in Vexim, a French medical device company that specializes in the minimally invasive treatment of vertebral fractures. Source: BioSpace

Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team. Source: BioSpace

The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace

Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace